Kezar Life Sciences, Inc. (KZR) Tops Q3 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q3 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• EQT Corp. (EQT) Tops Q1 EPS by 17c; offers outlook
• IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance